The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Critical reviews in oncogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1615/CRITREVONCOG.V8.I1.40PMID 9516087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.

  1997cited by this paper
• Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt

  1997cited by this paper
• Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor*

  1997cited by this paper
• The Constitutively Active Mutant Gα13Transforms Mouse Fibroblast Cells Deficient in Insulin-like Growth Factor-I Receptor*

  1997cited by this paper
• 14-3-3 (ε) Interacts with the Insulin-like Growth Factor I Receptor and Insulin Receptor Substrate I in a Phosphoserine-dependent Manner*

  1997cited by this paper
• Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product.

  1997cited by this paper
• Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal

  1997cited by this paper
• Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.

  1996cited by this paper
• Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA

  1996cited by this paper
• Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.

  1996cited by this paper
• The role of the insulin-like growth factor system in human cancer.

  1996cited by this paper
• Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.

  1996cited by this paper
• Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.

  1996cited by this paper
• Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins*

  1996cited by this paper
• Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.

  1996cited by this paper
• The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1 Fusion Protein*

  1996cited by this paper
• Epidermal growth factor and platelet-derived growth factor regulate the activity of the insulin-like growth factor I gene promoter.

  1996cited by this paper
• Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.

  1996cited by this paper
• The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.

  1995cited by this paper
• Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.

  1995cited by this paper
• Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15.

  1995cited by this paper
• The GC factor regulates the expression of the insulin‐like growth factor‐I receptor

  1995cited by this paper
• Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes

  1995cited by this paper
• Tumor suppressor p53 mutations and breast cancer: a critical analysis.

  1995cited by this paper
• Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression

  1995cited by this paper
• Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.

  1995cited by this paper
• Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

  1995cited by this paper
• Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.

  1995cited by this paper
• Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.

  1995cited by this paper
• Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.

  1995cited by this paper
• Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome.

  1995cited by this paper
• p53: a cell cycle regulator activated by DNA damage.

  1995cited by this paper
• The insulin-like growth factor I receptor: a key to tumor growth?

  1995cited by this paper
• The role of the IGF‐I receptor in the growth and transformation of mammalian cells

  1994cited by this paper
• Genetic events in the development of Wilms' tumor.

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.

  1994cited by this paper
• Oncogenes and the strategy of growth factors.

  1994cited by this paper
• Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.

  1994cited by this paper
• Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.

  1994cited by this paper
• Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts

  1994cited by this paper
• Growth regulation of human glioblastoma t98g cells by insulin‐like growth factor‐1 and its receptor

  1994cited by this paper
• Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.

  1994cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.

  1994cited by this paper
• Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.

  1994cited by this paper
• Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene.

  1994cited by this paper
• Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

  1994cited by this paper
• Human osteosarcoma (U‐2 OS) cells express both insulin‐like growth factor‐I (IGF‐I) receptors and insulin‐like growth factor‐II/mannose‐6‐phosphate (IGF‐II/M6P) receptors and synthesize IGF‐II: Autocrine growth stimulation by IGF‐II via the IGF‐I receptor

  1994cited by this paper
• The 5'-untranslated region of the IGF-I receptor gene modulates reporter gene expression by both pre- and post-transcriptional mechanisms.

  1994cited by this paper
• c phosphorylation and activation of the IGF-I receptor in src-transformed cells.

  1994cited by this paper
• Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewing's sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor.

  1994cited by this paper
• The genetics of Wilms' tumor--a case of disrupted development.

  1994cited by this paper
• The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer

  1994cited by this paper
• Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.

  1994cited by this paper
• Sequence-specific transcriptional activation is essential for growth suppression by p53.

  1994cited by this paper
• Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

  1994cited by this paper
• Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop

  1994cited by this paper
• Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

  1993cited by this paper
• Expression of IGF ligand and receptor genes during preimplantation mammalian development

  1993cited by this paper
• Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.

  1993cited by this paper
• Translocation (11;22)(p13;q12): Primary change in intra‐abdominal desmoplastic small round cell tumor

  1993cited by this paper
• Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

  1993cited by this paper
• Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice.

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.

  1993cited by this paper
• Apoptosis of human erythroid colony‐forming cells is decreased by stem cell factor and insulin‐like growth factor I as well as erythropoietin

  1993cited by this paper
• Insulin-like growth factor binding proteins.

  1993cited by this paper
• Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

  1993cited by this paper
• Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.

  1993cited by this paper
• Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development.

  1993cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Role of insulin-like growth factors in embryonic and postnatal growth.

  1993cited by this paper
• Tumor suppressor genes.

  1993cited by this paper
• Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

  1993cited by this paper
• The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor

  1993cited by this paper
• The insulin-like growth factors.

  1993cited by this paper
• WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

  1993cited by this paper
• Molecular regulation of apoptosis: genetic controls on cell death.

  1993cited by this paper
• Rapid isolation and characterization of amplified DNA by chromosome microdissection: identification of IGF1R amplification in malignant melanoma.

  1993cited by this paper
• Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).

  1993cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The Egr transcription factor family: from signal transduction to kidney differentiation.

  1992cited by this paper
• Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells.

  1992cited by this paper
• Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

  1992cited by this paper
• Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II.

  1992cited by this paper
• Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors.

  1992cited by this paper
• Cytogenetic abnormalities in an intraabdominal desmoplastic small cell tumor.

  1992cited by this paper
• p53: the ultimate tumor suppressor gene?

  1992cited by this paper
• Insulin-like growth factor I receptor gene structure.

  1992cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor.

  1992cited by this paper
• Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.

  1992cited by this paper
• Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

  1992cited by this paper

• Comprehensive bioinformatic profiling of matrix metalloproteinases and their inhibitors: Expression and interaction patterns in head and neck cancer toward predictive biomarkers and personalized therapies

  2024cites this paper
• Antiproliferative Activity and Mechanisms of Action of Plant-Derived Flavonoids on Breast Cancer.

  2023cites this paper
• Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord

  2023cites this paper
• Circulating concentrations of insulin like growth factor-1 in female dogs with spontane-ous mammary tumours

  2018cites this paper
• Effects of l-arginine on growth hormone and insulin-like growth factor 1

  2017cites this paper
• Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.

  2017cites this paper
• 144 – Growth Hormone, Prolactin, and Placental Lactogen in the Fetus and Newborn

  2017cites this paper
• Association between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males

  2016cites this paper
• Phytochemicals for breast cancer therapy: current status and future implications.

  2015cites this paper
• Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon.

  2015cites this paper
• Insulin-Like Growth Factor-2 Is Induced Following 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in SW620 Human Colon Cancer Cell Line

  2015influential citation
• Disorders of growth hormone/insulin-like growth factor secretion and action

  2014cites this paper
• IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival

  2014cites this paper
• Possible roles of insulin signaling in osteoblasts

  2014cites this paper
• Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar

  2014cites this paper
• The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects

  2013cites this paper
• Nuclear IGF1R is a transcriptional co‐activator of LEF1/TCF

  2012cites this paper
• Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours

  2012cites this paper
• State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors.

  2011cites this paper
• Normal and Aberrant Growth

  2011cites this paper
• Hormones, 1. Hormone Systems

  2011cites this paper
• Anti-tumor Activity of IGF-1R Kinase Inhibitor PQIP in Colon Cancer

  2011cites this paper
• The C. elegans DAF-2 insulin-like receptor is abundantly expressed in the nervous system and regulated by nutritional status.

  2011cites this paper
• Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.

  2011cites this paper
• Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.

  2011cites this paper
• Attenuation of IGF-I receptor signaling inhibits serum-induced proliferation of prostate cancer cells.

  2011cites this paper
• Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.

  2011cites this paper
• The Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair

  2010cites this paper
• Proline isosteres in a series of 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitors of IGF-1R kinase and IR kinase.

  2010cites this paper
• Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.

  2010cites this paper
• Targeting the p53 Pathway in Ewing Sarcoma

  2010cites this paper
• Molecular Targeted Therapy for Wilms’ Tumor

  2010cites this paper
• Pre Clinical and Clinical Studies of the Effects of Resveratrol, a Phytochemical With Potential Chemopreventive Efficacy

  2010cites this paper
• Estradiol, Testosteron, Belamcanda chinensis und Cimicifuga racemosa auf die Expression von IGF-1 in Knochen und Leber von orchiektomierten Ratten

  2009cites this paper
• Increased Prevalence of Insulin Resistance in Patients With Differentiated Thyroid Carcinoma

  2009cites this paper
• Breast cancer and therapeutic deployment of growth factor receptors.

  2009cites this paper
• The many faces of IGF-1R from cell surface to the nucleus

  2009cites this paper
• Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2

  2009cites this paper
• Right pelvic mass in a patient with a radically resected carcinoid of the appendix

  2009cites this paper
• Uveal melanoma and macular degeneration: molecular biology and potential therapeutic applications

  2008cites this paper
• Targeted therapy of the insulin-like growth factor-1 receptor in cancer.

  2008cites this paper
• The Insulin-like Growth Factor (IGF) system in breast and colorectal carcinogenesis: dietary intervention and molecular studies

  2008cites this paper
• Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.

  2008cites this paper
• CHAPTER 8 – Disorders of Growth Hormone/Insulin-like Growth Factor Secretion and Action

  2008cites this paper
• Receptors for the liver synthesized growth factors IGF‐1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications

  2008cites this paper
• Introduction: Uveal melanoma

  2008cites this paper
• Growth Inhibition of Insulin-Like Growth Factor I Receptor Monoclonal Antibody to Human Colorectal Cancer Cells

  2008cites this paper
• IGF-I protects human oral buccal mucosal epithelial cells from sodium nitroprusside-induced apoptosis via PI3-kinase.

  2008cites this paper
• Leukocyte Antigen-related Deficiency Enhances Insulin-like Growth Factor-1 Signaling in Vascular Smooth Muscle Cells and Promotes Neointima Formation in Response to Vascular Injury*

  2007cites this paper
• Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies.

  2007cites this paper
• Gene expression profiles in zebrafish (Danio rerio) liver cells exposed to a mixture of pharmaceuticals at environmentally relevant concentrations.

  2007cites this paper
• Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report.

  2007cites this paper
• Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.

  2007cites this paper
• Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States

  2007cites this paper
• RILM: a web‐based resource to aid comparative and functional analysis of the insulin and IGF‐1 receptor family

  2007cites this paper
• Single nucleotide polymorphisms in sporadic colorectal cancer

  2006cites this paper
• Regulation of apoptosis by insulin-like growth factor (IGF)-I.

  2006cites this paper
• Degradation of insulin‐like growth factor‐I receptor occurs via ubiquitin‐proteasome pathway in human lung cancer cells

  2006cites this paper
• Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.

  2006cites this paper
• High birth weight increases mammary tumorigenesis in rats

  2006cites this paper
• Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

  2006cites this paper
• In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors

  2005cites this paper
• The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.

  2005cites this paper
• Small-Molecule Receptor Tyrosine Kinase Inhibitors in Targeted Cancer Therapy

  2005cites this paper
• The IGF-I/IGF-I receptor pathway: Implications in the Pathophysiology of Thyroid Cancer.

  2005cites this paper
• Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.

  2005cites this paper
• A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity*

  2005cites this paper
• Role of Tumour Microenvironment in Chemoresistance

  2005cites this paper
• p53-independent activities of MDM2 and their relevance to cancer therapy.

  2005cites this paper
• The Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins in Postnatal Development of Murine Mammary Glands

  2004cites this paper
• The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy.

  2004cites this paper
• Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.

  2004cites this paper
• Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.

  2004cites this paper
• The Emerging Role of the Insulin-like Growth Factors in Oral Biology

  2004cites this paper
• Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

  2004cites this paper
• Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody*

  2004cites this paper
• Signal transduction pathways as novel therapy targets in lung cancer.

  2004cites this paper
• Associations among IRS 1 , IRS 2 , IGF 1 , and IGFBP 3 Genetic Polymorphisms and Colorectal Cancer

  2004cites this paper
• Anti-insulin-like growth factor strategies in breast cancer.

  2004cites this paper
• Inhibition of the Biologic Response to Insulin-like Growth Factor I in MCF-7 Breast Cancer Cells by a New Monoclonal Antibody to the Insulin-like Growth Factor-I Receptor. The Importance of Receptor Down-regulation

  2003cites this paper
• Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.

  2003cites this paper
• Suppression of insulin‐like growth factor signalling pathway and collagen expression in keloid‐derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids

  2003cites this paper
• Liver regeneration.

  2003cites this paper
• Insulin-like Growth Factor I (IGF-I) Stimulates Proliferation but also Increases Caspase-3 Activity, Annexin-V Binding, and DNA-fragmentation in Human MG63 Osteosarcoma Cells: Co-activation of Pro- and Anti-apoptotic Pathways by IGF-I

  2003cites this paper
• BRCA1–Sp1 interactions in transcriptional regulation of the IGF‐IR gene

  2003cites this paper
• Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.

  2003cites this paper
• Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor

  2003cites this paper
• Identification of Genes Associated with the Invasive Status of Human Mammary Carcinoma Cell Lines by Transcriptional Profiling

  2003cites this paper
• IGF-1 induces growth, survival and morphological change of primary hepatocytes on a galactose-bared polymer through both MAPK and beta-catenin pathways.

  2003cites this paper
• Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.

  2003cites this paper
• WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation*

  2003cites this paper
• With special emphasis on the insulin-like growth factor system

  2002cites this paper
• A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.

  2002cites this paper
• Cellular and molecular actions of estrogens and antiestrogens in breast cancer

  2002cites this paper
• The Breast Cancer Phenotype and Endocrine Response: Implications for New Drug Development Initiatives

  2002cites this paper
• Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer

  2002cites this paper
• Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein

  2002cites this paper
• Dysregulation of IGF-I signaling in uterine leiomyoma.

  2002cites this paper
• Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

  2002cites this paper
• Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function

  2002cites this paper